News + Filings Transactions Holdings
|
BAKER BROS. ADVISORS LP
|
|
Changes: All | New | Increased | Decreased | Sold Out |
Portfolio as of: |
Name | Ticker | Class | Shares | Change | Value | Change | % Port | % OS | Hist | Date |
Seagen Inc.
| SGEN | COM | 44,554,162 | -2,358,104 | 8,574,894,019,000 | 2,546,198,715,000 | 49.63 | |
Hist
| 06/30/2023 |
INCYTE CORP
| INCY | Common | 36,178,056 | 23,085 | 2,252,083,986,000 | -651,883,285,000 | 13.03 | 16.23 |
Hist
| 06/30/2023 |
BeiGene, Ltd.
| BGNE | ADR | 11,668,897 | 0 | 2,080,564,335,000 | -485,892,871,000 | 12.04 | |
Hist
| 06/30/2023 |
ACADIA PHARMACEUTICALS INC
| ACAD | Common | 42,864,612 | 941,126 | 1,026,607,457,000 | 359,185,560,000 | 5.94 | 26.36 |
Hist
| 06/30/2023 |
MADRIGAL PHARMACEUTICALS, INC.
| MDGL | Common | 1,545,113 | 0 | 356,921,103,000 | -91,547,945,000 | 2.07 | 8.45 |
Hist
| 06/30/2023 |
BIOMARIN PHARMACEUTICAL INC
| BMRN | Common | 3,810,248 | -3,810,246 | 330,272,297,000 | -458,372,627,000 | 1.91 | 2.04 |
Hist
| 06/30/2023 |
Immunocore Holdings plc
| IMCR | Common | 2,520,731 | 0 | 151,143,031,000 | 7,284,913,000 | 0.87 | |
Hist
| 06/30/2023 |
Kodiak Sciences Inc.
| KOD | Common | 17,310,490 | 0 | 119,442,381,000 | -4,500,727,000 | 0.69 | |
Hist
| 06/30/2023 |
Akero Therapeutics, Inc.
| AKRO | Common | 2,368,378 | 0 | 110,579,569,000 | -19,207,545,000 | 0.64 | 4.73 |
Hist
| 06/30/2023 |
ARGENX SE
| ARGX | SPONSORED ADR | 280,159 | 0 | 109,186,367,000 | 3,053,733,000 | 0.63 | |
Hist
| 06/30/2023 |
RHYTHM PHARMACEUTICALS, INC.
| RYTM | Common | 6,498,267 | 143,659 | 107,156,423,000 | -77,889,762,000 | 0.62 | 11.45 |
Hist
| 06/30/2023 |
Replimune Group, Inc.
| REPL | Common | 4,578,280 | 0 | 106,307,662,000 | -18,221,554,000 | 0.62 | 7.92 |
Hist
| 06/30/2023 |
AbCellera Biologics Inc.
| ABCL | Common | 16,450,180 | 6,000,000 | 106,268,163,000 | 407,840,000 | 0.62 | 5.72 |
Hist
| 06/30/2023 |
Kymera Therapeutics, Inc.
| KYMR | Common | 4,375,340 | 1,495,515 | 100,589,067,000 | 28,708,635,000 | 0.58 | 7.93 |
Hist
| 06/30/2023 |
Roivant Sciences Ltd.
| ROIV | COM | 9,428,592 | 8,711,939 | 95,040,207,000 | 89,314,150,000 | 0.55 | |
Hist
| 06/30/2023 |
BIOCRYST PHARMACEUTICALS INC
| BCRX | Common | 12,710,818 | 0 | 89,484,159,000 | -56,436,032,000 | 0.52 | 6.73 |
Hist
| 06/30/2023 |
SpringWorks Therapeutics, Inc.
| SWTX | Common | 2,999,846 | 1,471,308 | 78,655,962,000 | 38,898,689,000 | 0.46 | 4.80 |
Hist
| 06/30/2023 |
Entrada Therapeutics, Inc.
| TRDA | Common | 4,865,819 | 0 | 73,668,500,000 | 7,882,627,000 | 0.43 | 14.66 |
Hist
| 06/30/2023 |
Revolution Medicines, Inc.
| RVMD | Common | 2,691,493 | 2,469,271 | 71,997,438,000 | 66,704,110,000 | 0.42 | 2.53 |
Hist
| 06/30/2023 |
Immatics N.V.
| IMTX | Common | 5,640,816 | 453,735 | 65,095,017,000 | 19,915,541,000 | 0.38 | 7.36 |
Hist
| 06/30/2023 |
CHINOOK THERAPEUTICS, INC.
| KDNY | Common | 1,455,202 | -1,078,900 | 55,908,861,000 | -10,484,611,000 | 0.32 | 2.18 |
Hist
| 06/30/2023 |
Mirati Therapeutics, Inc.
| MRTX | COM | 1,409,784 | 0 | 50,935,496,000 | -12,941,817,000 | 0.29 | 2.42 |
Hist
| 06/30/2023 |
DICE Therapeutics, Inc.
| DICE | Common | 1,035,786 | 173,579 | 48,122,618,000 | 21,221,760,000 | 0.28 | 2.17 |
Hist
| 06/30/2023 |
Biomea Fusion, Inc.
| BMEA | Common | 2,108,949 | 4,390 | 46,291,431,000 | 28,549,999,000 | 0.27 | |
Hist
| 06/30/2023 |
Prelude Therapeutics Inc
| PRLD | Common | 10,123,824 | 0 | 45,557,208,000 | -15,590,689,000 | 0.26 | 21.11 |
Hist
| 06/30/2023 |
Denali Therapeutics Inc.
| DNLI | Common | 1,455,322 | 366,584 | 42,946,552,000 | 12,668,748,000 | 0.25 | 1.06 |
Hist
| 06/30/2023 |
Kiniksa Pharmaceuticals, Ltd.
| KNSA | Common | 2,809,577 | 10,000 | 39,558,844,000 | -2,378,819,000 | 0.23 | |
Hist
| 06/30/2023 |
CERUS CORP
| CERS | Common Stock | 16,067,558 | 0 | 39,526,193,000 | -19,120,394,000 | 0.23 | 9.05 |
Hist
| 06/30/2023 |
Nurix Therapeutics, Inc.
| NRIX | Common | 3,882,125 | 0 | 38,782,429,000 | -3,843,304,000 | 0.22 | 8.05 |
Hist
| 06/30/2023 |
Ultragenyx Pharmaceutical Inc.
| RARE | COM | 783,059 | 312,085 | 36,122,512,000 | 14,302,287,000 | 0.21 | |
Hist
| 06/30/2023 |
Aerovate Therapeutics, Inc.
| AVTE | Common | 1,963,479 | -13,389 | 33,673,665,000 | -24,248,567,000 | 0.19 | |
Hist
| 06/30/2023 |
IGM Biosciences, Inc.
| IGMS | Common | 3,157,210 | 1,108 | 29,141,048,000 | -24,544,247,000 | 0.17 | 7.31 |
Hist
| 06/30/2023 |
Xenon Pharmaceuticals Inc.
| XENE | COM | 751,639 | 0 | 28,938,102,000 | -699,024,000 | 0.17 | 1.18 |
Hist
| 06/30/2023 |
ImmunoGen, Inc.
| IMGN | COM | 1,520,097 | 1,520,097 | 28,684,230,000 | 28,684,230,000 | 0.17 | 0.67 |
Hist
| 06/30/2023 |
DBV Technologies S.A.
| DBVT | SPONSORED ADR | 14,614,264 | 0 | 27,767,102,000 | 5,407,278,000 | 0.16 | |
Hist
| 06/30/2023 |
<< Prev Next >> |
|
|
|
|